Ronit Satchi-Fainaro is a distinguished academic and researcher with extensive experience in cancer biology and nanomedicine. Currently serving as a Visiting Full Professor at the University of Lisbon and holding advisory roles at EFI - Entrepreneurship Forum Israel and 8400 - The Health Network, Ronit also contributes as a Director on the Board of Directors at Vall d’Hebron Institute of Research and Teva Pharmaceuticals. At Tel Aviv University, Ronit occupies several prestigious positions, including Director of the Cancer Biology Research Center and Full Professor with the Kurt and Herman Lion Chair in Nanosciences and Nanotechnologies. Previous roles include Visiting Associate Professor at Harvard Medical School and President of the Israeli Chapter of the Controlled Release Society. Ronit's educational background includes a Ph.D. from the University of London and postdoctoral studies at both Harvard Medical School and Tel Aviv University.
Links